Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oliff

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|July 5, 1989
Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonistsD C Heimbrook, W S Saari, N L Balishin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenograftsD C Heimbrook, S M Stirdivant, J D Ahern, et al.
Journal of Medicinal Chemistry|November 16, 2001
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.
Science (New York, N.Y.)|June 25, 1993
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitorN E Kohl, S D Mosser, S J deSolms, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
Cancer Research|April 15, 1989
Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explantsJ W Wallen, R L Cate, D M Kiefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosisP Nørgaard, B Law, H Joseph, et al.
Journal of Virology|February 1, 1993
Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of wartsD Defeo-Jones, G A Vuocolo, K M Haskell, et al.
The Journal of Biological Chemistry|December 6, 1996
Selection of potent inhibitors of farnesyl-protein transferase from a synthetic tetrapeptide combinatorial libraryA Wallace, K S Koblan, K Hamilton, et al.
Radiation Research|August 10, 2000
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRASE Cohen-Jonathan, R J Muschel, W Gillies McKenna, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|July 5, 1989
Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonistsD C Heimbrook, W S Saari, N L Balishin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenograftsD C Heimbrook, S M Stirdivant, J D Ahern, et al.
Journal of Medicinal Chemistry|November 16, 2001
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.
Science (New York, N.Y.)|June 25, 1993
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitorN E Kohl, S D Mosser, S J deSolms, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
Cancer Research|April 15, 1989
Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explantsJ W Wallen, R L Cate, D M Kiefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosisP Nørgaard, B Law, H Joseph, et al.
Journal of Virology|February 1, 1993
Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of wartsD Defeo-Jones, G A Vuocolo, K M Haskell, et al.
The Journal of Biological Chemistry|December 6, 1996
Selection of potent inhibitors of farnesyl-protein transferase from a synthetic tetrapeptide combinatorial libraryA Wallace, K S Koblan, K Hamilton, et al.
Radiation Research|August 10, 2000
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRASE Cohen-Jonathan, R J Muschel, W Gillies McKenna, et al.
Pageof 9